Discontinuation of concomitant immunosuppression in Crohn's disease patients treated with infliximab. Results from the Infliximab Maintenance Immunosuppressives Discontinuation (IMID) trial: a randomized multi-center trial

Discontinuation of concomitant immunosuppression in Crohn's disease patients treated with infliximab. Results from the Infliximab Maintenance Immunosuppressives Discontinuation (IMID) trial: a randomized multi-center trial

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gastroenterology (New York, N.Y. 1943) N.Y. 1943), 2008, Vol.134, p.1861-1868
Hauptverfasser: van Assche, G., Magdelaine-Beuzelin, Charlotte, d'Haens, G., Baert, Filip, Noman, M., Vermeire, S., Ternant, David, Watier, Hervé, Paintaud, Gilles, Rutgeerts, P.
Format: Artikel
Sprache:eng
Schlagworte:
Life Sciences
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1868
container_issue
container_start_page 1861
container_title Gastroenterology (New York, N.Y. 1943)
container_volume 134
creator van Assche, G.
Magdelaine-Beuzelin, Charlotte
d'Haens, G.
Baert, Filip
Noman, M.
Vermeire, S.
Ternant, David
Watier, Hervé
Paintaud, Gilles
Rutgeerts, P.
description
format Article
fullrecord <record><control><sourceid>hal</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_00318146v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>oai_HAL_hal_00318146v1</sourcerecordid><originalsourceid>FETCH-hal_primary_oai_HAL_hal_00318146v13</originalsourceid><addsrcrecordid>eNqVjstKxEAQRRtRMD7-oXY6i0j3xAzRncwoE3A24j6USYWUJN2hqzM-PtZvsQdF0J2rom6d4tw9lZh8XqRam_m-SuJYpLku8kN1JPKstb7KCpOojxVL7WxgO2FgZ8G1EPfaDRzQBuBhmKyTaRw9iewAtrD0rrNnAg0LoRCM8ZVsEAieMFADLxy6CLY9v_KATxfwQDL1EWi9GyB0BOXPETbINpBFW8f4t25LAn8LnpebcjWLKsb-GhA82ia2fY_aITo4rWMV8l_AiTposRc6_Z7HanZ3-7hcpx321eij379VDrla39xXu0zrzBTmcrE12X_YT1Kjesg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Discontinuation of concomitant immunosuppression in Crohn's disease patients treated with infliximab. Results from the Infliximab Maintenance Immunosuppressives Discontinuation (IMID) trial: a randomized multi-center trial</title><source>Elsevier ScienceDirect Journals Complete</source><source>Alma/SFX Local Collection</source><creator>van Assche, G. ; Magdelaine-Beuzelin, Charlotte ; d'Haens, G. ; Baert, Filip ; Noman, M. ; Vermeire, S. ; Ternant, David ; Watier, Hervé ; Paintaud, Gilles ; Rutgeerts, P.</creator><creatorcontrib>van Assche, G. ; Magdelaine-Beuzelin, Charlotte ; d'Haens, G. ; Baert, Filip ; Noman, M. ; Vermeire, S. ; Ternant, David ; Watier, Hervé ; Paintaud, Gilles ; Rutgeerts, P.</creatorcontrib><identifier>ISSN: 0016-5085</identifier><identifier>EISSN: 1528-0012</identifier><language>eng</language><publisher>Elsevier</publisher><subject>Life Sciences</subject><ispartof>Gastroenterology (New York, N.Y. 1943), 2008, Vol.134, p.1861-1868</ispartof><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-2139-4171 ; 0000-0003-0158-1356 ; 0000-0003-4020-4545 ; 0000-0002-2139-4171 ; 0000-0003-4020-4545 ; 0000-0003-0158-1356</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,4022</link.rule.ids><backlink>$$Uhttps://hal.science/hal-00318146$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>van Assche, G.</creatorcontrib><creatorcontrib>Magdelaine-Beuzelin, Charlotte</creatorcontrib><creatorcontrib>d'Haens, G.</creatorcontrib><creatorcontrib>Baert, Filip</creatorcontrib><creatorcontrib>Noman, M.</creatorcontrib><creatorcontrib>Vermeire, S.</creatorcontrib><creatorcontrib>Ternant, David</creatorcontrib><creatorcontrib>Watier, Hervé</creatorcontrib><creatorcontrib>Paintaud, Gilles</creatorcontrib><creatorcontrib>Rutgeerts, P.</creatorcontrib><title>Discontinuation of concomitant immunosuppression in Crohn's disease patients treated with infliximab. Results from the Infliximab Maintenance Immunosuppressives Discontinuation (IMID) trial: a randomized multi-center trial</title><title>Gastroenterology (New York, N.Y. 1943)</title><subject>Life Sciences</subject><issn>0016-5085</issn><issn>1528-0012</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNqVjstKxEAQRRtRMD7-oXY6i0j3xAzRncwoE3A24j6USYWUJN2hqzM-PtZvsQdF0J2rom6d4tw9lZh8XqRam_m-SuJYpLku8kN1JPKstb7KCpOojxVL7WxgO2FgZ8G1EPfaDRzQBuBhmKyTaRw9iewAtrD0rrNnAg0LoRCM8ZVsEAieMFADLxy6CLY9v_KATxfwQDL1EWi9GyB0BOXPETbINpBFW8f4t25LAn8LnpebcjWLKsb-GhA82ia2fY_aITo4rWMV8l_AiTposRc6_Z7HanZ3-7hcpx321eij379VDrla39xXu0zrzBTmcrE12X_YT1Kjesg</recordid><startdate>2008</startdate><enddate>2008</enddate><creator>van Assche, G.</creator><creator>Magdelaine-Beuzelin, Charlotte</creator><creator>d'Haens, G.</creator><creator>Baert, Filip</creator><creator>Noman, M.</creator><creator>Vermeire, S.</creator><creator>Ternant, David</creator><creator>Watier, Hervé</creator><creator>Paintaud, Gilles</creator><creator>Rutgeerts, P.</creator><general>Elsevier</general><scope>1XC</scope><orcidid>https://orcid.org/0000-0002-2139-4171</orcidid><orcidid>https://orcid.org/0000-0003-0158-1356</orcidid><orcidid>https://orcid.org/0000-0003-4020-4545</orcidid><orcidid>https://orcid.org/0000-0002-2139-4171</orcidid><orcidid>https://orcid.org/0000-0003-4020-4545</orcidid><orcidid>https://orcid.org/0000-0003-0158-1356</orcidid></search><sort><creationdate>2008</creationdate><title>Discontinuation of concomitant immunosuppression in Crohn's disease patients treated with infliximab. Results from the Infliximab Maintenance Immunosuppressives Discontinuation (IMID) trial: a randomized multi-center trial</title><author>van Assche, G. ; Magdelaine-Beuzelin, Charlotte ; d'Haens, G. ; Baert, Filip ; Noman, M. ; Vermeire, S. ; Ternant, David ; Watier, Hervé ; Paintaud, Gilles ; Rutgeerts, P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-hal_primary_oai_HAL_hal_00318146v13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Life Sciences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van Assche, G.</creatorcontrib><creatorcontrib>Magdelaine-Beuzelin, Charlotte</creatorcontrib><creatorcontrib>d'Haens, G.</creatorcontrib><creatorcontrib>Baert, Filip</creatorcontrib><creatorcontrib>Noman, M.</creatorcontrib><creatorcontrib>Vermeire, S.</creatorcontrib><creatorcontrib>Ternant, David</creatorcontrib><creatorcontrib>Watier, Hervé</creatorcontrib><creatorcontrib>Paintaud, Gilles</creatorcontrib><creatorcontrib>Rutgeerts, P.</creatorcontrib><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Gastroenterology (New York, N.Y. 1943)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van Assche, G.</au><au>Magdelaine-Beuzelin, Charlotte</au><au>d'Haens, G.</au><au>Baert, Filip</au><au>Noman, M.</au><au>Vermeire, S.</au><au>Ternant, David</au><au>Watier, Hervé</au><au>Paintaud, Gilles</au><au>Rutgeerts, P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Discontinuation of concomitant immunosuppression in Crohn's disease patients treated with infliximab. Results from the Infliximab Maintenance Immunosuppressives Discontinuation (IMID) trial: a randomized multi-center trial</atitle><jtitle>Gastroenterology (New York, N.Y. 1943)</jtitle><date>2008</date><risdate>2008</risdate><volume>134</volume><spage>1861</spage><epage>1868</epage><pages>1861-1868</pages><issn>0016-5085</issn><eissn>1528-0012</eissn><pub>Elsevier</pub><orcidid>https://orcid.org/0000-0002-2139-4171</orcidid><orcidid>https://orcid.org/0000-0003-0158-1356</orcidid><orcidid>https://orcid.org/0000-0003-4020-4545</orcidid><orcidid>https://orcid.org/0000-0002-2139-4171</orcidid><orcidid>https://orcid.org/0000-0003-4020-4545</orcidid><orcidid>https://orcid.org/0000-0003-0158-1356</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0016-5085
ispartof Gastroenterology (New York, N.Y. 1943), 2008, Vol.134, p.1861-1868
issn 0016-5085
1528-0012
language eng
recordid cdi_hal_primary_oai_HAL_hal_00318146v1
source Elsevier ScienceDirect Journals Complete; Alma/SFX Local Collection
subjects Life Sciences
title Discontinuation of concomitant immunosuppression in Crohn's disease patients treated with infliximab. Results from the Infliximab Maintenance Immunosuppressives Discontinuation (IMID) trial: a randomized multi-center trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T14%3A30%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-hal&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Discontinuation%20of%20concomitant%20immunosuppression%20in%20Crohn's%20disease%20patients%20treated%20with%20infliximab.%20Results%20from%20the%20Infliximab%20Maintenance%20Immunosuppressives%20Discontinuation%20(IMID)%20trial:%20a%20randomized%20multi-center%20trial&rft.jtitle=Gastroenterology%20(New%20York,%20N.Y.%201943)&rft.au=van%20Assche,%20G.&rft.date=2008&rft.volume=134&rft.spage=1861&rft.epage=1868&rft.pages=1861-1868&rft.issn=0016-5085&rft.eissn=1528-0012&rft_id=info:doi/&rft_dat=%3Chal%3Eoai_HAL_hal_00318146v1%3C/hal%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true